Your browser doesn't support javascript.
loading
A validated UHPLC-MS/MS method for determination of TQ-B3203 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.
Yang, Fen; Zhou, Jun; Bo, Yunhai; Yin, Han; Liu, Xiao Hong; Li, Jian.
Afiliación
  • Yang F; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
  • Zhou J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
  • Bo Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
  • Yin H; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
  • Liu XH; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
  • Li J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
J Sep Sci ; 44(5): 945-953, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33340437

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: J Sep Sci Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: J Sep Sci Año: 2021 Tipo del documento: Article